Original articleLung cancerSecond-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma
Lung cancer
Under an Elsevier user license
open archive
Key words
malignant pleural mesothelioma
pemetrexed
second-line chemotherapy
Cited by (0)
Copyright © 2005 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.